tranexamic acid has been researched along with Bone Neoplasms in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TXA) has been shown to decrease perioperative blood loss, transfusions, and cost in patients undergoing resection of aggressive bone tumors and endoprosthetic reconstruction." | 1.72 | Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction. ( Bombardier, B; Haase, DR; Kimbrel, B; Mersereau, EJ; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2022) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss in orthopaedic procedures." | 1.56 | Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review. ( Haase, DR; Rosenthal, HG; Sweeney, KR; Templeton, KJ, 2020) |
| "Fibrinogen level was normalized within two days (2." | 1.43 | Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report. ( Cvetković, Z; Kulić, A; Libek, V, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haase, DR | 3 |
| Kimbrel, B | 2 |
| Bombardier, B | 2 |
| Templeton, KJ | 3 |
| Rosenthal, HG | 3 |
| Sweeney, KR | 3 |
| Mersereau, EJ | 1 |
| Kulić, A | 1 |
| Cvetković, Z | 1 |
| Libek, V | 1 |
4 other studies available for tranexamic acid and Bone Neoplasms
| Article | Year |
|---|---|
Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Cost Analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Bone Neoplasms; Hospi | 2021 |
Tranexamic acid improves early postoperative mobilization in cancer patients undergoing endoprosthetic reconstruction.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Bone Neoplasms; Humans; Postoperative Hemorrhage; Ret | 2022 |
Tranexamic Acid in Patients With Cancer Undergoing Endoprosthetic Reconstruction: A Retrospective Review.
Topics: Antifibrinolytic Agents; Bone Neoplasms; Femur; Humans; Plastic Surgery Procedures; Postoperative He | 2020 |
Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
Topics: Adenocarcinoma; Antifibrinolytic Agents; Biomarkers; Blood Coagulation Disorders; Blood Coagulation | 2016 |